ConductScience.org, home

Paper41900935

Pharmacomicrobiomics in Psoriasis: Microbiome-Drug Interactions Across Systemic Treatments.

Santaniello U and 6 others. Life (Basel), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Pharmacomicrobiomics in Psoriasis: Microbiome-Drug Interactions Across Systemic Treatments. Papers, record 41900935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41900935

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacomicrobiomics in Psoriasis: Microbiome-Drug Interactions Across Systemic Treatments.
PubMed
Journal
Life (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Santaniello UUmbertohttps://orcid.org/0009-0008-7728-6832
2Mastorino LLucahttps://orcid.org/0000-0001-7386-3219
3Pala VValentina
4Rosset FFrancois
5Crespi OOrsolahttps://orcid.org/0009-0001-9270-1204
6Quaglino PPietro
7Ribero SSimonehttps://orcid.org/0000-0002-0098-1406

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129130553The Akkermansia muciniphila is a gut microbiota signature in psoriasis.Exp Dermatol2018https://conductscience.org/library/papers/29130553PubMed
239328313The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials.Front Med (Lausanne)2024https://conductscience.org/library/papers/39328313PubMed
331958048Encapsulated cyclosporine does not change the composition of the human microbiota when assessed ex vivo and in vivo.J Med Microbiol2020https://conductscience.org/library/papers/31958048PubMed
433926088Psoriasis and Gut Microbiome-Current State of Art.Int J Mol Sci2021https://conductscience.org/library/papers/33926088PubMed
540504322Unravelling the gut-skin axis: the role of gut microbiota in pathogenesis and management of psoriasis.Inflammopharmacology2025https://conductscience.org/library/papers/40504322PubMed
636483198Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats.Front Microbiol2022https://conductscience.org/library/papers/36483198PubMed
736159864Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis.Front Immunol2022https://conductscience.org/library/papers/36159864PubMed
838686385IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy.Front Immunol2024https://conductscience.org/library/papers/38686385PubMed
929559344Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial.J Invest Dermatol2018https://conductscience.org/library/papers/29559344PubMed
1040192577Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL-17A Inhibitors: A Population-Based Study.Aliment Pharmacol Ther2025https://conductscience.org/library/papers/40192577PubMed
1139399065Oral Microbiota Variations in Psoriasis Patients Without Comorbidity.Clin Cosmet Investig Dermatol2024https://conductscience.org/library/papers/39399065PubMed
1212207634Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.Br J Clin Pharmacol2002https://conductscience.org/library/papers/12207634PubMed
1334263334Characterization of the Oral and Gut Microbiota in Patients with Psoriatic Diseases: A Systematic Review.Acta Derm Venereol2021https://conductscience.org/library/papers/34263334PubMed
1440128037Analysis of the therapeutic effect of acitretin capsules combined with cooling blood and detoxifying formula on psoriasis hemorrhagic fever and its impact on the gut microbiota of patients.Medicine (Baltimore)2025https://conductscience.org/library/papers/40128037PubMed
1538796266Biologics for Psoriasis.Dermatol Clin2024https://conductscience.org/library/papers/38796266PubMed
1637908308The Skin Microbiome and Its Role in Psoriasis: A Review.Psoriasis (Auckl)2023https://conductscience.org/library/papers/37908308PubMed
1728653490The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis.J Eur Acad Dermatol Venereol2017https://conductscience.org/library/papers/28653490PubMed
1831549347Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.Clin Drug Investig2019https://conductscience.org/library/papers/31549347PubMed
1939720714Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes.Front Immunol2024https://conductscience.org/library/papers/39720714PubMed
2039770590A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents.Microorganisms2024https://conductscience.org/library/papers/39770590PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42921249Gut microbiota-host immunity crosstalk in psoriasis: from dysbiosis to cutaneous inflammation.Front Immunol2026https://conductscience.org/library/papers/42921249

Source PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
TYK27297PubTator's text mininghttps://conductscience.org/library/genes/7297NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41900935

GET https://conductscience.org/api/papers/v1/41900935/references?page=2